Methods of monitoring acceptance criteria of pharmaceutical manufacturing processes

• US 8,660,680 B2
• Filed: 01/29/2009
• Issued: 02/25/2014
• Est. Priority Date: 05/06/2004
• Status: Active Grant

• Current Assignee: SMP Logic Systems LLC
• Original Assignee: SMP Logic Systems LLC
• Inventors: Popp, Shane M.
• Primary Examiner(s): Shechtman, Sean
• Assistant Examiner(s): GARLAND, STEVEN R
• Application Number:
  US12/322,180
• Publication Number:
  US 20090143892A1
• Time in Patent Office: 1,853 Days
• Field of Search: 700/110, 700/109, 702/19, 705 1- 3
• US Class Current: 700/110
• CPC Class Codes: G05B 2219/11 Plc I-O input output
• CPC Class Codes: G05B 2219/1112 Bit addressing, handling
• CPC Class Codes: G05B 2223/02 Indirect monitoring, e.g. monitoring production to detect faults of a system
• CPC Class Codes: G05B 23/0224 Process history based detection method, e.g. whereby history implies the availability of large amounts of data
• CPC Class Codes: G05B 23/0235 based on a comparison with predetermined threshold or range, e.g. "classical methods", carried out during normal operation; threshold adaptation or choice; when or how to compare with the threshold
• CPC Class Codes: G06Q 10/06 Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling

Abstract

Methods of monitoring an acceptance criteria of pharmaceutical manufacturing processes are described and disclosed herein. Consequently, the methods provide a means to perform validation and quality control on an integrated level whereby a pharmaceutical manufacturer can ensure data and product integrity and minimize cost.

Claims

1. A method of monitoring an acceptance criteria of a pharmaceutical manufacturing batch process and taking corrective action said method comprising,

a) monitoring data generated by a pharmaceutical manufacturing batch process during pharmaceutical manufacture wherein said pharmaceutical manufacture produces an in-process material;

b) maintaining the data over time to provide a historical record, wherein said historic record is associated with a distinct batch number;

c) analyzing the historical record and providing a comparative analysis against an acceptance criteria wherein said acceptance criteria is determined at initial batch process said acceptance criteria comprising product specifications, an acceptable quality level, an unacceptable quality level, with an associated sampling plan;

d) taking corrective action to obviate a rejection determined by the comparative analysis against the acceptance criteria whereby said corrective action comprises modifying said pharmaceutical batch manufacture wherein said pharmaceutical manufacture produces an in-process material.

2. The method of claim 1, wherein said historic record is further associated with a distinct lot number.

3. The method of claim 1, wherein said historic record is further associated with a distinct control number.

4. The method of claim 1, wherein the monitoring is continuous.

5. The method of claim 1, whereby the monitoring occurs at initial process.

6. The method of claim 1, whereby the monitoring occurs at end process.

7. The method of claim 1, wherein the monitoring is part of routine maintenance.

8. A non-transitory computer memory having computer readable instructions which performs the method of claim 1.

9. Article of manufacture comprising the non-transitory computer memory having computer readable instructions of claim 8.